Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Taxane‐based Chemohormonal Therapy for Metastatic Hormone‐sensitive Prostate Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439794/all/Taxane‐based_chemohormonal_therapy_for_metastatic_hormone‐sensitive_prostate_cancer_New. Accessed 26 April 2024.
Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439794/all/Taxane‐based_chemohormonal_therapy_for_metastatic_hormone‐sensitive_prostate_cancer_New. Accessed April 26, 2024.
Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439794/all/Taxane‐based_chemohormonal_therapy_for_metastatic_hormone‐sensitive_prostate_cancer_New
Taxane‐based Chemohormonal Therapy for Metastatic Hormone‐sensitive Prostate Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 April 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439794/all/Taxane‐based_chemohormonal_therapy_for_metastatic_hormone‐sensitive_prostate_cancer_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer
ID - 439794
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439794/all/Taxane‐based_chemohormonal_therapy_for_metastatic_hormone‐sensitive_prostate_cancer_New
DB - Evidence Central
DP - Unbound Medicine
ER -